For instance, TNM II + III GC with higher intratumoral CXCR5 + CD8+ T cell infiltration is more likely to benefit from adjuvant chemotherapy and the infiltrating CXCR5 + CD8 + T cells shows a specific subtype of stem-like CD8+ T with effector memory features [16]. This evidence concerns the gene CXCR5 and gastric cancer.